174 related articles for article (PubMed ID: 22850549)
1. A retrospective observational study examining the characteristics and outcomes of tumours diagnosed within and without of the English NHS Bowel Cancer Screening Programme.
Morris EJ; Whitehouse LE; Farrell T; Nickerson C; Thomas JD; Quirke P; Rutter MD; Rees C; Finan PJ; Wilkinson JR; Patnick J
Br J Cancer; 2012 Aug; 107(5):757-64. PubMed ID: 22850549
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests.
Logan RF; Patnick J; Nickerson C; Coleman L; Rutter MD; von Wagner C;
Gut; 2012 Oct; 61(10):1439-46. PubMed ID: 22156981
[TBL] [Abstract][Full Text] [Related]
3. Reduced risk of emergency admission for colorectal cancer associated with the introduction of bowel cancer screening across England: a retrospective national cohort study.
Geraghty J; Shawihdi M; Devonport E; Sarkar S; Pearson MG; Bodger K
Colorectal Dis; 2018 Feb; 20(2):94-104. PubMed ID: 28736972
[TBL] [Abstract][Full Text] [Related]
4. The National Health Service Bowel Cancer Screening Program: the early years.
Rees CJ; Bevan R
Expert Rev Gastroenterol Hepatol; 2013 Jul; 7(5):421-37. PubMed ID: 23899282
[TBL] [Abstract][Full Text] [Related]
5. Comparison of screen-detected and interval colorectal cancers in the Bowel Cancer Screening Programme.
Gill MD; Bramble MG; Rees CJ; Lee TJ; Bradburn DM; Mills SJ
Br J Cancer; 2012 Jul; 107(3):417-21. PubMed ID: 22782347
[TBL] [Abstract][Full Text] [Related]
6. Screen-detected and interval colorectal cancers in England: Associations with lifestyle and other factors in women in a large UK prospective cohort.
Blanks R; Burón Pust A; Alison R; He E; Barnes I; Patnick J; Reeves GK; Floud S; Beral V; Green J
Int J Cancer; 2019 Aug; 145(3):728-734. PubMed ID: 30694563
[TBL] [Abstract][Full Text] [Related]
7. Screen-detected colorectal cancers are associated with an improved outcome compared with stage-matched interval cancers.
Gill MD; Bramble MG; Hull MA; Mills SJ; Morris E; Bradburn DM; Bury Y; Parker CE; Lee TJ; Rees CJ
Br J Cancer; 2014 Nov; 111(11):2076-81. PubMed ID: 25247322
[TBL] [Abstract][Full Text] [Related]
8. Exploring the decision to participate in the National Health Service Bowel Cancer Screening Programme.
Ekberg M; Callender M; Hamer H; Rogers S
Eur J Cancer Prev; 2014 Sep; 23(5):391-7. PubMed ID: 24418799
[TBL] [Abstract][Full Text] [Related]
9. Ileocolonic neuroendocrine tumours identified in the English bowel cancer screening programme.
Basuroy R; O'Donnell CM; Srirajaskanthan R; Ramage JK
Colorectal Dis; 2018 Apr; 20(4):O85-O91. PubMed ID: 29368418
[TBL] [Abstract][Full Text] [Related]
10. Analysis of colorectal cancer outcomes for the Australian National Bowel Cancer Screening Program.
;
Asia Pac J Clin Oncol; 2016 Mar; 12(1):22-32. PubMed ID: 26803949
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of bowel cancer registration data in England, 1996-2004.
Jones AM; Morris E; Thomas J; Forman D; Melia J; Moss SM
Br J Cancer; 2009 Oct; 101(8):1269-73. PubMed ID: 19773758
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
Murphy J; Halloran S; Gray A
BMJ Open; 2017 Oct; 7(10):e017186. PubMed ID: 29079605
[TBL] [Abstract][Full Text] [Related]
13. Inappropriate use of the faecal occult blood test outside of the National Health Service colorectal cancer screening programme.
Peacock O; Watts ES; Hanna N; Kerr K; Goddard AF; Lund JN
Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1270-5. PubMed ID: 22872076
[TBL] [Abstract][Full Text] [Related]
14. Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme.
Lee TJ; Rutter MD; Blanks RG; Moss SM; Goddard AF; Chilton A; Nickerson C; McNally RJ; Patnick J; Rees CJ
Gut; 2012 Jul; 61(7):1050-7. PubMed ID: 21940723
[TBL] [Abstract][Full Text] [Related]
15. Slipping through the bowel cancer screening programme.
Hallifax R; Lacey M; Bevis P; Borley NR; Brooklyn T; Wheeler JM
Colorectal Dis; 2012 Jul; 14(7):844-7. PubMed ID: 21920009
[TBL] [Abstract][Full Text] [Related]
16. Faecal occult blood testing screening for colorectal cancer and 'missed' interval cancers: are we ignoring the elephant in the room? Results of a multicentre study.
George AT; Aggarwal S; Dharmavaram S; Menon A; Dube M; Vogler M; Field A
Colorectal Dis; 2017 May; 19(5):O108-O114. PubMed ID: 27992095
[TBL] [Abstract][Full Text] [Related]
17. Variations in the management of significant polyps and early colorectal cancer: results from a multicentre observational study of 383 patients.
Dattani M; Crane S; Battersby NJ; Di Fabio F; Saunders BP; Dolwani S; Rutter MD; Moran BJ;
Colorectal Dis; 2018 Dec; 20(12):1088-1096. PubMed ID: 29999580
[TBL] [Abstract][Full Text] [Related]
18. Impact of the UK colorectal cancer screening pilot studies on incidence, stage distribution and mortality trends.
McClements PL; Madurasinghe V; Thomson CS; Fraser CG; Carey FA; Steele RJ; Lawrence G; Brewster DH
Cancer Epidemiol; 2012 Aug; 36(4):e232-42. PubMed ID: 22425027
[TBL] [Abstract][Full Text] [Related]
19. Screen-detected colorectal cancers show improved cancer-specific survival when compared with cancers diagnosed via the 2-week suspected colorectal cancer referral guidelines.
Courtney ED; Chong D; Tighe R; Easterbrook JR; Stebbings WS; Hernon J
Colorectal Dis; 2013 Feb; 15(2):177-82. PubMed ID: 22709315
[TBL] [Abstract][Full Text] [Related]
20. Impact of the Scottish Bowel Cancer Screening Programme on patient and tumour characteristics at a single centre.
Mackay C; Ramsay G; Rafferty A; Loudon M
J Eval Clin Pract; 2014 Feb; 20(1):7-11. PubMed ID: 23890078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
